| Cardiovascular Risk Management |
1 |
1 |
| Coronary Artery Disease (CAD) |
0 |
0.67 |
| Cardiovascular disease |
0 |
0.63 |
| Lipids Management |
0 |
0.63 |
| Statins |
0 |
0.55 |
| Patient Safety |
0 |
0.36 |
| Adverse Effects |
0 |
0.32 |
| Blood Dyscrasia |
0 |
0.22 |
| Liver Disease |
0 |
0.22 |
| Blood |
0 |
0.16 |
| Impairment |
0 |
0.16 |
| Aplastic Anemia |
0 |
0.11 |
| Abdomen |
0 |
0.08 |
| Anemia |
0 |
0.08 |
| Cerebrovascular Accident |
0 |
0.08 |
| Clinical Research |
0 |
0.08 |
| Diarrhea |
0 |
0.08 |
| Fertility |
0 |
0.08 |
| Gout |
0 |
0.08 |
| Granulocytopenia |
0 |
0.08 |
| Healthcare and Medical Technology |
0 |
0.08 |
| Heart |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Infarction |
0 |
0.08 |
| LDL Cholesterol |
0 |
0.08 |
| Leukopenia |
0 |
0.08 |
| Myalgia |
0 |
0.08 |
| Myelosuppression |
0 |
0.08 |
| Myocardial Infarction (MI) |
0 |
0.08 |
| Pain Management |
0 |
0.08 |
| Pancytopenia |
0 |
0.08 |
| Pericarditis |
0 |
0.08 |
| Renal Failure |
0 |
0.08 |
| Rhabdomyolysis |
0 |
0.08 |
| Stress |
0 |
0.08 |
| Thrombocytopenia |
0 |
0.08 |
| Toxicology |
0 |
0.08 |